Sponsored by:

Nuclear Medicine: Page 227

SCCT: Cardiac PET/CTA improves diagnosis and planning
By Eric Barnes
Hybrid PET/CT angiography (CTA) offers a full cardiac assessment in a single exam, compensating for each modality's weaknesses in heart imaging, according to results presented on Friday at the Society of Cardiovascular Computed Tomography (SCCT) meeting in Denver.
July 14, 2011
GE launches MIND Coalition
By AuntMinnie.com staff writers
GE Healthcare has unveiled its new Making an Impact on Neurodegenerative Diseases (MIND) initiative to help physicians improve the worldwide detection, diagnosis, and management of neurological conditions such as Alzheimer's and Parkinson's disease.
July 14, 2011
Naviscan taps new board member
By AuntMinnie.com staff writers
PET developer Naviscan announced that it has named Dr. Andre Cheng, PhD, to its board of directors.
July 13, 2011
Protocols protect pediatric caregivers from I-131 exposure
By Wayne Forrest
With the right protocols and precautions in place, caregivers who take care of pediatric neuroblastoma patients can avoid high levels of radiation exposure from iodine-131 metaiodobenzylguanidine (I-131 MIBG) therapy.
July 12, 2011
New PET tracers can help identify Alzheimer's lesions
By Wayne Forrest
Researchers are reporting positive results with two new PET tracers being developed to help diagnose Alzheimer's disease. The tracers, flutemetamol and florbetapir, may enable earlier diagnosis of Alzheimer's by identifying beta-amyloid plaque in brain tissue, according to two studies published July 11 in Archives of Neurology.
July 10, 2011
Zecotek nets PET patent
By AuntMinnie.com staff writers
Nuclear medicine firm Zecotek Photonics has received a patent on its technology for enhancing the performance of PET scanning and other medical imaging systems.
July 7, 2011
Sofie awarded DOE grant
By AuntMinnie.com staff writers
Molecular imaging developer Sofie Biosciences has received a grant from the U.S. Department of Energy (DOE) to advance the development of a benchtop, PC-controlled, microscale, chip-based commercial device for the on-demand production of PET radiopharmaceutical probes.
July 7, 2011
CMS targets imaging again; AECL deal ignores moly plight; new AuntMinnieMobile upgrade
By Brian Casey
July 6, 2011
AECL sale does not include NRU reactor
By AuntMinnie.com staff writers
The Canadian government has reached a deal to sell assets in its Atomic Energy of Canada (AECL) commercial reactor division to SNC-Lavalin Group. The sale does not include the National Research Universal (NRU) reactor, however, which supplies molybdenum to North America.
July 6, 2011
Eckert & Ziegler to buy Bioscan unit
By AuntMinnie.com staff writers
Eckert & Ziegler Radiopharma has reached an agreement to acquire Bioscan's radiopharmaceutical equipment business.
July 5, 2011
FDG-PET has low radiation risk to fetus in pregnant patients
By Wayne Forrest
While radiation exposure to a fetus from an FDG-PET scan is low, every effort should be made to minimize exposure by modifying the imaging protocol, according to a study in the July issue of the Journal of Nuclear Medicine.
July 4, 2011
2011 07 01 14 43 34 514 Fdg Pet Fetus Thumb
Survey shows regional imaging cost disparity
By AuntMinnie.com staff writers
Employee healthcare benefits advisory firm Change:Healthcare found significant regional disparity in the cost of imaging studies in the U.S. in its quarterly Healthcare Transparency Index.
July 3, 2011
Previous Page
Page 227 of 440
Next Page